c-Cbl: A regulator of T cell receptor-mediated signalling

Immunology and Cell Biology

Volumn 76, Issue 5, 1998, Pages 473-482

  Thien, Christine B F ^a   Langdon, Wallace Y ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cbl; Protein tyrosine kinases; Signal transduction; T cell receptor

Indexed keywords

CELL SURFACE RECEPTOR; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR;

AMINO TERMINAL SEQUENCE; CAENORHABDITIS ELEGANS; CONFERENCE PAPER; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMUS;

ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; HELMINTH PROTEINS; MICE; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; THYMUS GLAND; UBIQUITIN-PROTEIN LIGASES;

CAENORHABDITIS ELEGANS;

EID: 0031759356     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1998.00768.x     Document Type: Conference Paper

References (90)

1. Langdon WY, Hartley JW, Klinken SP, Ruscetti SK, Morse III HC. v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc. Natl Acad. Sci. USA 1989; 86: 1168-72.
2. Langdon WY, Hyland CD, Grumont RJ, Morse III HC. The c-cbl proto-oncogene is preferentially expressed in thymus and testis tissue and encodes a nuclear protein. J. Virol. 1989; 63: 5420-4.
3. Blake TJ, Shapiro M, Morse III HC, Langdon WY. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 1991; 6: 653-7.
4. Lupher Jr ML, Reedquist KA, Miyake S, Langdon WY, Band H. A novel PTB domain in the N-terminal transforming region of Cbl interacts directly and selectively wth ZAP-70 in T cells. J. Biol. Chem. 1996; 271: 24 063-8.
5. Thien CBF, Langdon WY. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene. Oncogene 1997; 14: 2239-49.
6. Hofmann K, Bucher P. UBA domain: A sequence motif present in multiple enzyme classes of ubiquitin pathway. Trends Biochem. Sci. 1996; 21: 172-3.
7. Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC, Lipkowitz S. Cloning and characterization of cbl-b: A SH3-binding protein with homology to the c-cbl proto-oncogene. Oncogene 1995; 10: 2367-77.
8. Hime GR, Dhungat MP, Ng A, Bowtell DDL. D-Cbl, the Drosophila homologue of the c-Cbl proto-oncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding sites. Oncogene 1997; 14: 2709-19.
9. Meisner H, Daga A, Buxton J et al. Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development. Mol. Cell. Biol. 1997; 17: 2217-25.
10. Yoon CH, Lee J, Jongeward GD, Sternberg PW. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science 1995; 269: 1102-5.
11. Bustelo XR, Crespo P, López-Barahona M, Gutkind JS, Barbacid M. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mcdiated c-Jun N-terminal kinase activation. Oncogene 1997; 15: 2511-20.
12. Andoniou CE, Thien CBF, Langdon WY. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J. 1994; 13: 4515-23.
13. Andoniou CE, Thien CBF, Langdon WY. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain. Oncogene 1996; 12: 1981-9.
14. Bowtell DDL, Langdon WY. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation. Oncogene 1995; 11: 1561-7.
15. Donovan JA, Wange RL, Langdon WY, Samelson LH. The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J. Biol. Chem. 1994; 269: 22 921-4.
16. Buday L, Khwaja A, Sipeki S, Harago A, Downward J. Interactions of Cbl with two adaptor proteins, Grb2 and Crk, upon T cell activation. J. Biol. Chem. 1996; 271: 6159-63.
17. Cory GOC, Lovering RC, Hinshelwood S, MacCarthy-Morrogh L, Levinski RJ, Kinnon C. The protein product of the c-cbl proto-oncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J. Exp. Med. 1995; 182: 611-15.
18. cbl in antigen receptor-ligated B cells. J. Biol. Chem. 1995; 270: 27 504-9.
19. cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol. 3-kinase. J. Biol. Chem. 1996; 271: 3187-94.
20. Kontani K, Kukimoto I, Nishina H et al. Tyrosine phosphorylation of the c-cbl proto-oncogene product mediated by cell surface antigen CD38 in HL-60 cells. J. Biol. Chem. 1996; 271: 1534-7.
21. Kitanaka A, Ito C, Nishigaki H, Campana D. CD38-mediated growth suppression of B-cell progenitors requires activation of phosphalidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene. Blood 1996; 88: 590-8.
22. Kitanaka A, Ito C, Coustan-Smith E, Campana D. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase. J. Immunol. 1997; 159: 184-92.
23. Cerboni C, Gismondi A, Palmieri G, Piccoli M, Frati L, Santoni A. CD16-mediated activation of phosphatidylinositol-3 kinase (PI-3K) in human NK cells involves tyrosine phosphorylation of Cbl and its association with Grb2. Shc, pp36 and p85 PI-3K subunit. Eur. J. Immunol. 1998; 28: 1005-15.
24. Dennehy KM, Broszeit R, Ferris WF, Beyers AD. Thymocyte activation induces the association of the proto-oncogene c-Cbl and ras GTPase-activating protein with CD5. Eur. J. Immunol. 1998; 28: 1617-25.
25. Marcilla A, Rivero-Lezcano OM, Agarwal A, Robbins KC. Identification of the major tyrosine kinase substrate in signaling complexes formed after engagement of Fc gamma receptors. J. Biol. Chem. 1995; 270: 9115-20.
26. Ota Y, Beitz LO, Scharenberg AM, Donovan JA, Kinet J-P, Samelson LE. Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells. J. Exp. Med. 1996; 184: 1713-23.
27. Tanaka S, Neff L, Baron R, Levy J. Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J. Biol. Chem. 1995; 270: 14347-51.
28. Galisteo ML, Dikic I, Batzer AG, Langdon WY, Schlessinger J. Tyrosine phosphorylation of the c-cbl proto-oncogene product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J. Biol. Chem. 1995; 270: 20 241-5.
29. Meisner H, Czech MP. Coupling of the proto-oncogene product c-cbl to the epidermal growth factor receptor. J. Biol. Chem. 1995; 270: 25 332-5.
30. Bonita DP, Miyake S, Lupher Jr ML, Langdon WY, Band H. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor α signaling cascade by transforming mutants of Cbl: Implications for Cbl's function and oncogenicity. Mol. Cell. Biol. 1997; 17: 4597-610.
31. Wang Y, Yeung YG, Langdon WY, Stanley ER. c-cbl is transiently tyrosine-phosphorylated, ubiquinated, and membrane-targeted following CSF-1 stimulation of macrophages. J. Biol. Chem. 1996; 271: 17-20.
32. Wisniewski D, Strife A, Clarkson B. c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells. Leukemia 1996; 10: 1436-42.
33. Hunter S, Koch BL, Anderson SM. Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase. Mol. Endocrinol. 1997; 11: 1213-22.
34. Brizzi MF, Dentelli P, Lanfrancone L, Rosso A, Pelicci PG, Pegoraro L. Discrete protein interactions with the Grb2/c-Cbl complex in SCF-and TPO-mediated myeloid cell proliferation. Oncogene 1996; 13: 2067-76.
35. Odai H, Sasaki K, Iwamatsu A et al. The proto-oncogene product c-cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J. Biol. Chem. 1995; 270: 10 800-6.
36. Barber DL, Mason JM, Fukazawa T et al. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of Cbl and association with Crk adaptor proteins. Blood 1997; 89: 3166-74.
37. Gesbert F, Garbay C, Bertoglio J. Interleukin-2 stimulation induces tyrosine phosphorylation of p120-Cbl and CrkL and formation of multimolecular signaling complexes in T lymphocytes and natural killer cells. J Biol. Chem. 1998; 273: 3986-93.
38. Anderson SM, Burton FA, Koch BL. Phosphorylation of Cbl following stimulation with interleukin-3 and its association with Grb2, Fyn, and phosphatidylinositol 3-kinase. J. Biol. Chem. 1997; 272: 739-45.
39. Ueno H, Sasaki K, Honda H et al. c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3′-kinase pathway. Blood 1998; 91: 46-53.
40. Uddin S, Gardziola C, Dangat A, Yi T, Platanias LC. Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase. Biochem. Biophys. Res. Comm. 1996; 225: 833-8.
41. cbl links c-Src and phosphalidylinositol 3′-kinase to the integrin signaling pathway. J. Biol. Chem. 1997; 272: 3780-7.
42. HEFI. J. Biol. Chem. 1997; 272: 14 320-6.
43. Jongeward GD, Clandinin TR, Sternberg PW. sli-1, a negative regulator of let-23-mediated signaling in C. elegans. Genetics 1995; 139: 1553-66.
44. Ota Y, Samelson LE. The product of the proto-oncogene c-Cbl a negative regulator of the Syk tyrosine kinase. Science 1997; 276: 418-20.
45. Rellahan BL, Graham LJ, Stocia B, DeBell KE, Bonvini E. Cbl-mediated regulation of T cell receptor-induced AP-1 activation. J. Biol. Chem. 1997; 272: 30 806-11.
46. 2+-stimulated activation of nuclear factor of activated T cells by a constitutively active Cbl mutant in T cells. J. Biol. Chem. 1997; 272: 168-73.
47. Thien CBF, Langdon WY. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl. Oncogene 1997; 15: 2909-19.
48. Ueno H, Sasaki K, Miyagawa K et al. Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the Ras pathway in epidermal growth factor receptor signaling. J. Biol. Chem. 1997; 272: 8739-43.
49. Fukazawa T, Reedquist KA, Trub T et al. The SH3 domain-binding T cell tyrosyl phosphoprotein p120: Demonstration of its identity with the c-cbl protooncogene and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase. J. Biol. Chem. 1995; 270: 19 141-50.
50. Rivero-Lezcano OM, Sameshima JH, Marcilla A, Robbins KC. Physical association between Src homology 3 elements and the protein product of the c-cbl proto-oncogene. J. Biol. Chem. 1994; 269: 17 363-6.
51. Ribon V, Printen JA, Hoffman NG, Kay BK, Saltiel AR. A novel, multifunctional c-Cbl binding protein in insulin receptor signaling in 3T3 L1 adipocytes. Mol. Cell. Biol. 1998; 18: 872-9.
52. Sabe H, Okada M, Nakagawa H, Hanafusa H. Activation of c-Src in cells bearing v-Crk and its suppression by Csk. Mol. Cell. Biol. 1992; 12: 4706-13.
53. Sawasdikosol S, Chang J-H, Pratt JC, Wolf G, Shoelson SE, Burakoff SJ. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation. J. Immunol. 1996; 157: 110-16.
54. Ribon V, Hubbell S, Herrera R, Saltiel AR. The product of the cbl oncogene forms stable complexes in vivo with endogenous crk in a tyrosine phosphorylation-dependent manner. Mol. Cell. Biol. 1996; 16: 45-52.
55. Andoniou CE, Thien CBF, Langdon WY. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain. Oncogene 1996; 12: 1981-9.
56. Meisner H, Conway BR, Hartley D, Czech MP. Interactions of Cbl with Grb2 and phosphatidylinositol 3′-kinase in activated Jurkat cells. Mol. Cell. Biol. 1995; 15: 3571-8.
57. lck-independent mechanism. J. Biol. Chem. 1996; 271: 21939-43.
58. Marengére LEM, Mirtsos C, Kozieradzki I, Veillette A, Mak TW, Penninger JM. Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells. J. Immunol. 1997; 159: 70-6.
59. Deckert M, Elly C, Altman A, Liu YC. Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases. J. Biol. Chem. 1998; 273: 8867-74.
60. Lupher ML, Songyang Z, Shoelson SE, Cantley LC, Band H. The Cbl phosphotyrosine-binding domain selects a D (N D) XpY motif and binds to the TyrP292 negative regulatory phosphorylation site of ZAP-70. J. Biol. Chem. 1997; 272: 33140-4.
61. Liu Y-C, Elly C, Yoshida H, Bonnefoy-Berard N, Altman A. Activation-modulated association of 14-3-3 proteins with Cbl in T cells. J. Biol. Chem. 1996; 271: 14 591-5.
62. Liu YC, Liu Y, Elly C, Yoshida H, Lipkowitz S, Altman A. Serine phosphorylation of Cbl induced by phorbol ester enhances its association with 14-3-3 proteins in T cells via a novel serine-rich 14-3-3-binding motif. J. Biol. Chem. 1997; 272: 9979-85.
63. cbl with Grb2 in Jurkat T cells. J. Biol. Chem. 1996; 271: 26369-74.
64. lyn, in the B cell antigen receptor-mediated signaling. J. Exp. Med. 1996; 183: 675-80.
65. c cbl in T lymphocytes. J. Exp. Med. 1996; 183: 301-6.
66. Feshchenko EA, Langdon WY, Tsygankov AY. Fyn, Yes and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells. J. Biol. Chem. 1998; 273: 8323-31.
67. Tsygankov AY, Mahajan S, Fincke JE, Holen JB. Specific association of tyrosine-phosphorylated c-Cbl with Fyn tyrosine kinase in T cells. J. Biol. Chem. 1996; 271: 27 130-7.
68. Reedquist KA, Fukazawa T, Panchamoorthy G et al. Stimulation through the T cell receptor induces cbl association with crk proteins and the guanine nucleotide exchange protein C3G. J. Biol. Chem. 1996; 271: 8435-51.
69. Gotoh T, Hattori S, Nakamura S et al. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol. 1995; 15: 6746-53.
70. Nassar N, Horn G, Herrmann C, Scherer A, McCormick F, Wittinghofer A. The 2.2A crystal structure of the Ras-binding domain of the serine threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature 1995; 375: 554-60.
71. Boussiotis VA, Freeman GJ, Berezovskaya A, Barber DL, Nadler LM. Maintenance of human T cell anergy: Blocking of IL-2 gene transcription by activated Rap1. Science 1997; 278: 124-8.
72. Salojin K, Zhang J, Cameron M et al. Impaired plasma membrane targeting of Grb2-murine Son of Sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-ζ-Cbl pathway mediate T cell hyporesponsiveness in autoimmune nonobese diabetic mice. J. Exp. Med. 1997; 186: 887-97.
73. Collins TL, Deckert M, Altman A. Views on Vav. Immunol. Today 1997; 18: 221-5.
74. Wu J, Motto DG, Koretzky GA, Weiss A. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 1996; 4: 593-602.
75. Jain SK, Langdon WY, Varticovski L. Tyrosine phosphorylation of p120 cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase. Oncogene 1997; 14: 2217-28.
76. Hartley D, Meisner H, Corvera S. Specific association of the β isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl. J. Biol. Chem. 1995; 270: 18260-3.
77. Crooks ME, Littman DR, Carter RH, Fearon DT, Weiss A, Stein PH. CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation. Mol. Cell. Biol. 1995; 15: 6820-8.
78. Shimizu T, Mobley JL, Finkelstein LD, Chan AS. A role for phosphatidylinositol 3-kinase in the regulation of beta 1 integrin activity by the CD2 antigen. J. Cell Biol. 1995; 131: 1867-80.
79. Joly M, Kazaluskas A, Fay Fs, Corvera S. Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science 1994; 263: 684-7.
80. Watts JD, Affolter M, Krebs DL, Wange RL, Samelson LE, Aebersold R. Identification by electrospray ionization mass spectrometry of the sites of tyrosine phosphorylation induced in activated Jurkat T cells on the protein tyrosine kinase ZAP-70. J. Biol. Chem. 1994; 269: 29521-9.
81. Chan AC, Dalton M, Johnson R et al. Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J. 1995; 14: 2499-508.
82. Wange RL, Gultian R, Isakov N, Watts JD, Aebersold R, Samelson LE. Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70. J. Biol. Chem. 1995; 270: 18 730-3.
83. Kong G, Dalton M, Wardenburg JB, Straus D, Kurosaki T, Chan AC. Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function. Mol. Cell. Biol. 1996; 16: 5026-35.
84. Murphy MA, Schnall RG, Venter DJ et al. Tissue hyperplasia and enhanced T cell signalling via ZAP-70 in c-Cbl deficient mice. Mol. Cell. Biol. 1998; 18: 4872-820.
85. Wardenburg JB, Fu C, Jackman JK et al. Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function. J. Biol. Chem. 1996; 271: 19 641-4.
86. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE. LAT: The ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998; 92: 83-92.
87. Wange RL, Samelson LE. Complex complexes: Signaling at the TCR. Immunity 1996; 5: 1-20.
88. Cantrell D. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 1996; 14: 259-74.
89. van Oers NSC, Killeen N, Weiss A. Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J. Exp. Med. 1996; 183: 1053-62.
90. Wiest DL, Ashe JM, Abe R, Bolen JB, Singer A. TCR activation of ZAP70 is impaired in CD4+CD8+ thymocytes as a consequence of intrathymic interactions that diminish available p56lck. Immunity 1996; 4: 495-504.